医疗保健服务平台GoodRx Holdings, Inc.近日宣布，通过与制药公司Viatris的合作，符合条件的参保患者在使用特定处方药时，自付费用可大幅降低至0至4美元区间。该计划旨在减轻患者用药负担，提升药品可及性。
此次合作涵盖Viatris旗下多款常用药物，符合条件的投保人通过GoodRx平台获取优惠后，部分药物自付费用可低至4美元，甚至完全免费。这一举措将显著降低慢性病患者的长期用药成本。
医疗保健服务平台GoodRx Holdings, Inc.近日宣布，通过与制药公司Viatris的合作，符合条件的参保患者在使用特定处方药时，自付费用可大幅降低至0至4美元区间。该计划旨在减轻患者用药负担，提升药品可及性。
此次合作涵盖Viatris旗下多款常用药物，符合条件的投保人通过GoodRx平台获取优惠后，部分药物自付费用可低至4美元，甚至完全免费。这一举措将显著降低慢性病患者的长期用药成本。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.